Skip to main content

PD-1 inhibitors

Research in Review
11/17/2016
JCP Editors
Using PD-L1 expression to determine non-small cell lung cancer (NSCLC) treatment is becoming standard of care, according to a presentation given at the 11th Annual New York Lung Cancer Symposium (November 12,...
Using PD-L1 expression to determine non-small cell lung cancer (NSCLC) treatment is becoming standard of care, according to a presentation given at the 11th Annual New York Lung Cancer Symposium (November 12,...
Using...
11/17/2016
Journal of Clinical Pathways